Related Experiment Video
Updated: Jan 16, 2026

A New Method for Inducing a Depression-Like Behavior in Rats
Published on: February 22, 2018
Neighborhood Deprivation and Suicide Among Adolescent and Young Adult Cancer Patients
Abhery Das1, Cecily A Byrne2, Vanessa M Oddo3
1Health Policy & Administration, School of Public Health, University of Illinois Chicago, Chicago, Illinois, USA.
Background:
In 2024, approximately 84,100 adolescents and young adults (AYAs) between 15 and 39 years old received a cancer diagnosis.
Aims:
Given their unique psychosocial, economic, and clinical stressors, we examined whether AYA cancer patients living in deprived neighborhoods have a higher risk of suicide when compared to those in the least deprived neighborhoods.
Materials & Methods:
Our sample comprised 486,374 AYA cancer patients from the Surveillance, Epidemiology, and End Results (SEER) dataset between 2006 and 2020. We use Cox proportional hazard models to test the relation between quintiles of neighborhood deprivation, from Q1 (most deprived) to Q5 (least deprived), and survival months until suicide mortality from the time of cancer diagnosis.
Results:
We find that AYA cancer patients living in more deprived neighborhoods (Q1, Q2, Q4) have a higher risk of suicide when compared to those in the least deprived neighborhoods (Q5) (Q1: HR-1.82 [1.14-2.90]; Q2: HR-1.95 [1.35-2.81]; Q4: HR-1.48 [1.05-2.07]).
Discussion:
Mental health services and monitoring from treatment through survivorship may support suicide prevention efforts for young cancer patients.
Conclusion:
Early identification of high-risk AYA cancer patients living in deprived areas may help target suicide prevention interventions.
Related Concept Videos
Cancer Survival Analysis
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer
Psychoneuroimmunology: Diabetes and Cancer
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

